These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23037012)

  • 1. Axonal transport and mitochondrial dysfunction in Alzheimer's disease.
    Riemer J; Kins S
    Neurodegener Dis; 2013; 12(3):111-24. PubMed ID: 23037012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new hypothesis for early pathogenesis in Alzheimer's disease: impaired axonal transport mechanism].
    Zhu YB; Lu PH; Sheng ZH
    Sheng Li Ke Xue Jin Zhan; 2008 Jan; 39(1):5-9. PubMed ID: 18357680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X; Su B; Perry G; Smith MA; Zhu X
    Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease.
    Kins S; Lauther N; Szodorai A; Beyreuther K
    Neurodegener Dis; 2006; 3(4-5):218-26. PubMed ID: 17047360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
    von Bernhardi R; Eugenín J
    Antioxid Redox Signal; 2012 May; 16(9):974-1031. PubMed ID: 22122400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
    Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
    Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits.
    Ye X; Tai W; Zhang D
    Neurobiol Aging; 2012 Jun; 33(6):1122.e1-10. PubMed ID: 22212405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
    Götz J; Ittner LM; Kins S
    J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.